Overall, these data indicate that in combination it may be that various salivary MV biomarkers including HSP90α, HSP90β, TRAP1, HSP105, VEGF-C, annexin V and laminin-332 could be of use in tumour detection, staging and prognosis. The gene discussed is ANXA5; the disease is neoplasm.